Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate
2. Ipd 1151t
3. Ipd-1151t
1. Suplatast Tosylate
2. 94055-76-2
3. Ipd 1151t
4. Ipd-1151t
5. Suplatast (tosilate)
6. Suplatasttosilate
7. Suplatast Tosilate [inn]
8. 94055-76-2 (tosylate)
9. C9j89787u1
10. (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate
11. Dsstox_cid_25003
12. Dsstox_rid_80646
13. Dsstox_gsid_45003
14. [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate
15. Sulfonium, (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethyl-, Salt With 4-methylbenzenesulfonic Acid (1:1)
16. Suplatastum Tosilas
17. Cas-94055-76-2
18. Ccris 6596
19. Tosilate De Suplatast
20. Tosilato De Suplatast
21. Suplatastum Tosilas [inn-latin]
22. Ncgc00181000-01
23. Tosilate De Suplatast [inn-french]
24. Tosilato De Suplatast [inn-spanish]
25. Unii-c9j89787u1
26. [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethylsulfonium 4-methylbenzenesulfonate
27. Mfcd00867604
28. Ym-672
29. Ipd (tn)
30. (+-)-(2-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyldimethylsulfonium P-tosylate
31. Schembl29042
32. Mls006010745
33. Suplatast Tosilate (jan/inn)
34. Chembl115435
35. Suplatast Tosylate [mi]
36. Dtxsid9045003
37. Suplatast Tosilate [jan]
38. Hms3413p08
39. Hms3655l09
40. Hms3677p08
41. Suplatast Tosilate [mart.]
42. Amy40561
43. Bcp10310
44. Suplatast Tosilate [who-dd]
45. Tox21_112652
46. S2015
47. Suplatast Tosylate, >=98% (hplc)
48. Akos015900359
49. Tox21_112652_1
50. Ccg-269685
51. Cs-0574
52. Ks-1288
53. Ncgc00181000-02
54. (+-)-(2-((p-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate
55. Hy-17002
56. Smr004701701
57. Ft-0650625
58. S0875
59. Sw219352-1
60. C77240
61. D01423
62. Q7644399
63. 2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyldimethylsulfonium P-toluenesulfonate
64. (3-(4-(3-ethoxy-2-hydroxypropoxy)phenylamino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate
Molecular Weight | 499.6 g/mol |
---|---|
Molecular Formula | C23H33NO7S2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 10 |
Exact Mass | 499.16984474 g/mol |
Monoisotopic Mass | 499.16984474 g/mol |
Topological Polar Surface Area | 134 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 500 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?